Respiratory Monitoring Devices Market Report 2025

This Respiratory Monitoring Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The respiratory monitoring devices market size has grown rapidly in recent years. It will grow from $1.67 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to respiratory diseases, aging population, technological advancements, hospital and homecare settings.

The respiratory monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to respiratory health awareness, chronic diseases, remote patient monitoring, wearable technology. Major trends in the forecast period include remote monitoring and telehealth, connected devices and iot, data analytics and artificial intelligence, mobile apps and wearable devices.

The growth of the respiratory monitoring devices market is anticipated to be driven by the increasing incidence of chronic respiratory diseases. Conditions like asthma, bronchitis, pneumonia, and others, often resulting from various bacterial and viral infections, are expected to create a greater demand for respiratory monitoring devices. For instance, in June 2023, The Centers for Disease Control and Prevention, a US-based public health agency, reported 142,342 deaths from chronic lower respiratory diseases in 2021. Similarly, The Australian Institute of Health and Welfare, an Australia-based national agency, revealed that nearly one-third of Australians, or 7.5 million people, have been diagnosed with chronic respiratory diseases. These respiratory monitoring devices, including spirometers and pulse oximeters, play a crucial role in monitoring vital respiratory parameters.

The increasing prevalence of pneumonia is expected to drive the growth of the respiratory monitoring devices market. Pneumonia is an infection that impacts one or both lungs, causing the alveoli (air sacs in the lungs) to fill with fluid or pus. This infection triggers inflammation in the lungs, which increases blood vessel permeability and leads to fluid leakage into the alveoli. Respiratory monitoring devices can assist in the early detection and management of pneumonia by offering real-time, continuous monitoring of respiratory rate and other vital signs. For example, in January 2023, the National Center for Biotechnology Information, a US-based government agency, reported that pneumonia affects around 120 million people globally each year, resulting in approximately 1.3 million deaths. Nearly 80% of pneumonia-related deaths in children occur in those under 2 years old in developing countries. As such, the rising prevalence of pneumonia is driving the demand for respiratory monitoring devices.

Companies in the market are increasingly introducing smart respiratory monitoring devices for the diagnosis and monitoring of respiratory diseases. These smart devices are Bluetooth-enabled and can be linked to smartphones for continuous monitoring of essential respiratory parameters. For instance, in February 2022, Aptar Pharma, a US-based manufacturer of drug delivery systems, unveiled HeroTracker® Sense, a digital respiratory health solution that transforms a standard metered dose inhaler into a smart connected healthcare device. It aids patients in tracking their inhaler usage and adhering to prescribed doses.

Leading companies in the respiratory monitoring devices market are focusing on product innovation, such as the HeroTracker Sense, to offer reliable services to their customers. The HeroTracker Sense is a respiratory monitoring device designed to assist with patient inhalation techniques and medication adherence. For example, in February 2022, AptarGroup, Inc., a US-based provider of innovative drug delivery systems for the pharmaceutical industry, introduced HeroTracker Sense. This device transforms a standard metered dose inhaler (pMDI) into a smart, connected healthcare tool. HeroTracker Sense supports asthma and chronic obstructive pulmonary disease (COPD) patients in taking their medications, while collecting healthcare analytics to help doctors and healthcare providers deliver more effective care.

In June 2022, Senzime AB, a US-based patient monitoring systems manufacturer, acquired Respiratory Motion for an initial cash payment of $19 million. This strategic acquisition expands Senzime's product portfolio in the monitoring devices market, strengthening the company's capabilities. Respiratory Motion is a US-based manufacturer of respiratory medical devices.

Respiratory monitoring devices are used to evaluate the patient's respiratory organs and include patches applied to the body to measure respiration and heart rates. These devices help assess respiratory health, identify abnormalities, and guide treatment in clinical environments.

The primary categories of respiratory monitoring devices include capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and other related equipment. Capnographs, for example, are devices used to monitor the concentration of carbon dioxide in exhaled air, providing both a numerical readout and a graphical waveform tracing. These devices find applications in various medical contexts, including chronic obstructive pulmonary disease (COPD) management, the diagnosis and monitoring of infectious diseases, asthma treatment, and other respiratory health assessments. These devices are used by a range of end-users, including laboratories, hospitals, and individuals for home use.

The respiratory monitoring devices market research report is one of a series of new reports that provides respiratory monitoring devices market statistics, including respiratory monitoring devices industry global market size, regional shares, competitors with a respiratory monitoring devices market share, detailed respiratory monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory monitoring devices industry. This respiratory monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the respiratory monitoring devices market include Covidien LLC, GE Healthcare Inc., Philips Healthcare, ResMed Corp., Siemens Healthcare GmbH, Merck & Co. Inc., Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Sirnaomics Inc., Traversa Therapeutics Inc., CareFusion Corporation, Smiths Medical ASD Inc., Masimo Corporation, COSMED S.r.l., IITC Life Science Inc., Micro Idea Instruments Co. Ltd., OES Medical Ltd., Pulmonx Corporation, RWD Life Science Co. Ltd., Scientific Respiratory Equipment Inc., AirSep Corporation, Medtronic PLC, Drägerwerk AG & Co. KGaA, Hamilton Medical India Pvt. Ltd., Getinge AB, Respiratory Motion Inc., Genstar Technologies Co. Inc., Avery Biomedical Devices Inc., Dynarex Corporation, Quality Medical Group Ltd.

Asia-Pacific was the largest region in the respiratory monitoring devices market in 2024. North America was the second-largest region in the respiratory monitoring devices market. The regions covered in the respiratory monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The respiratory monitoring devices market consists of sales of pulse oximeters, capnography, spirometers, polysomnography (PSG), peak flow meters, gas analyzers, and others that are used to monitor respiration and heart rate. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.